Sai Parenteral's Ltd (NSE:SAIPARENT) Share Price

Company Profile

Business description
Sai Parenteral's Ltd is a diversified pharmaceutical formulations company. Its business is organised in two verticals: (i) Branded Generic Formulations: Through the branded generics portfolio, it serves the domestic market with formulations across multiple therapeutic areas. and (ii) Contract Development and Manufacturing Organisation (CDMO): It provides CDMO services to pharmaceutical companies, supporting activities from product development to commercial manufacturing. Its product portfolio includes cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, etc. The majority of the company's revenue is derived from the Branded Generic Formulations business.
Contact
Plot No 39, 5th floor
Lavanya Arcade Jayabheri Enclave, Gachibowli
K.V.Rangareddy
Seri Lingampally
HyderabadTG500032
IND
T: +91 7997991301
https://www.saiparenterals.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees

Recommended

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Ananya Chag | 27 April 2026

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,935.00	14.40	-0.16%
CAC 40	8,112.92	29.00	-0.36%
DAX 40	24,033.15	50.38	-0.21%
Dow JONES (US)	49,149.78	18.01	-0.04%
FTSE 100	10,310.41	10.68	-0.10%
HKSE	25,679.78	245.87	-0.95%
NASDAQ	24,700.74	186.36	-0.75%
Nikkei 225	59,917.46	619.90	-1.02%
NZX 50 Index	12,764.40	110.54	-0.86%
S&P 500	7,139.99	33.92	-0.47%
S&P/ASX 200	8,710.70	10.50	-0.12%
SSE Composite Index	4,078.64	7.71	-0.19%